Rik Joos

The enduring role of sulfasalazine in the treatment of juvenile idiopathic arthritis: a retrospective cohort study on safety and effectiveness

Abstract Background Sulfasalazine (SSZ) is a commonly used disease-modifying antirheumatic drug for juvenile idiopathic arthritis (JIA) that is primarily recommended within the group of juvenile spondyloarthropathies. Current treatment guidelines increasingly limit its role in th...